Nutriband Inc. (NTRBW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 4Aug 7Aug 12Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.4x

Market Cap

$6.63M

MomentumView details →

1D Return

−6.78%

YTD Return

−63.35%

RSI (14)

54.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.4x

Market Cap

$6.63M

RSI (14)

54.7

MomentumView details →

1D Return

−6.78%

YTD Return

−63.35%

ProfitabilityView details →

Gross Margin

28.35%

Net Margin

−448.39%

EBITDA Margin

−437.73%

ROE (TTM)

−134.94%

ROA (TTM)

−117.27%

Asset Turnover

0.25x

GrowthView details →

Revenue YoY

−24.84%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

−0.69%

EPS CAGR 3Y

—

EBITDA YoY

+18.49%

EarningsView details →

EPS (Actual)

−$0.10

EPS Surprise

—

Beats (12Q)

2/12

Next Q EPS Est

—

Avg Surprise (4Q)

18.72%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.04x

Current Ratio

5.26x

Quick Ratio

5.11x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

1.80M

Net Income (TTM)

−8.08M

Op. CF (TTM)

−4.36M

Next earningsSep 30, 2026 →

Latest newsMore news →

No recent news for NTRBW.

Similar companies

Addex Therapeutics LtdADXN GRI Bio, Inc.GRI Ernexa Therapeutics Inc.ERNA Enveric Biosciences, Inc.ENVB XTL Biopharmaceuticals Ltd.XTLB Reviva Pharmaceuticals Holdings, Inc.RVPH Find similar companies →

Latest newsMore news →

No recent news for NTRBW.